• News
  • SAN DIEGO
  • BioTech

Ligand receives equity milestone payment from Retrophin

La Jolla-based Ligand Pharmaceuticals Inc. (Nasdaq: LGND) received a milestone payment of 620,000 shares of common stock in newly public partner Retrophin Inc. (OTCQB: RTRX).

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!